Precigen Inc (PGEN)
1.28
-0.01
(-0.78%)
USD |
NASDAQ |
May 10, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Precigen Free Cash Flow: -68.47M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -68.47M |
| September 30, 2023 | -67.10M |
| June 30, 2023 | -75.25M |
| March 31, 2023 | -68.15M |
| December 31, 2022 | -69.97M |
| September 30, 2022 | -71.88M |
| June 30, 2022 | -65.78M |
| March 31, 2022 | -65.98M |
| December 31, 2021 | -63.02M |
| September 30, 2021 | -63.59M |
| June 30, 2021 | -64.33M |
| March 31, 2021 | -71.05M |
| December 31, 2020 | -84.55M |
| September 30, 2020 | -14.17M |
| June 30, 2020 | -29.07M |
| March 31, 2020 | -60.69M |
| December 31, 2019 | -84.55M |
| September 30, 2019 | -185.58M |
| June 30, 2019 | -188.24M |
| March 31, 2019 | -179.92M |
| December 31, 2018 | -165.83M |
| September 30, 2018 | -165.10M |
| June 30, 2018 | -163.94M |
| Date | Value |
|---|---|
| March 31, 2018 | -160.02M |
| December 31, 2017 | -150.39M |
| September 30, 2017 | -131.16M |
| June 30, 2017 | -120.62M |
| March 31, 2017 | -103.78M |
| December 31, 2016 | -80.62M |
| September 30, 2016 | -42.55M |
| June 30, 2016 | 33.13M |
| March 31, 2016 | 30.81M |
| December 31, 2015 | 22.92M |
| September 30, 2015 | 3.265M |
| June 30, 2015 | -54.60M |
| March 31, 2015 | -48.48M |
| December 31, 2014 | -26.23M |
| September 30, 2014 | -26.49M |
| June 30, 2014 | -34.74M |
| March 31, 2014 | -34.25M |
| December 31, 2013 | -55.21M |
| September 30, 2013 | -57.40M |
| June 30, 2013 | -56.53M |
| March 31, 2013 | -64.81M |
| December 31, 2012 | -69.02M |
Free Cash Flow Range, Past 5 Years
-188.24M
Minimum
Jun 2019
-14.17M
Maximum
Sep 2020
-76.92M
Average
-68.15M
Median
Mar 2023
Free Cash Flow Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.12M |
| HealthEquity Inc | 196.75M |
| Corvus Pharmaceuticals Inc | -23.97M |
| Oragenics Inc | -7.291M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.77M |
| Cash from Investing (Quarterly) | 13.29M |
| Free Cash Flow Per Share (Quarterly) | -0.0675 |
| Free Cash Flow to Equity (Quarterly) | -16.81M |
| Free Cash Flow to Firm (Quarterly) | -16.81M |
| Free Cash Flow Yield | -21.94% |